AIMS Social Equity Entheogenic Care Partnership

The Advanced Integrative Medical Science (AIMS) Institute in Seattle is a multi-specialty teaching clinic and research institute founded in 2018 offering cutting edge care in oncology, psychiatry, neurology, rehabilitation, pain, and palliative care. We provide coordinated, team-based care by licensed and board-certified allopathic medical and psychiatric specialists, specialized naturopathic physicians, psychotherapists, advanced practice and registered nurses, a social worker, and targeted health educators, with the majority of care covered by insurance, including Medicare. Additionally incorporated are novel ‘advanced’ approaches, such as entheogen-assisted psychotherapy using ketamine and hopefully soon psilocybin, medical cannabis education, sympathetic ganglion blocks, and advanced intravenous therapies which are generally considered experimental and uncovered by insurance. AIMS Institute works with our partners and the U.S. FDA and DEA towards conducting the first human study of ayahuasca tea therapy in the U.S. and is petitioning the DOJ/DEA in Court for access to psilocybin under the Right-to-Try law. AIMS Institute conducts IRB-approved prospective clinical outcomes studies to evaluate the safety and effectiveness of their therapy programs.

We are excited to improve the reach of our patient care and research mission by partnering with the Social Equity Entheogenic Care Fund.

Beyond Tribalism: Dr. Leanna Standish, Awake launch event, Nov 21, 2021

AIMS vs. DEA and AIMS Entheogenic Social Equity Care Fund

Click here to learn how you can donate to or apply for financial aid with the AIMS and Awake.net partnership.

Latest Blog Posts

A Holistic Solution to Health Disparities: Naturopathic Medicine and Culturally Competent Care

Healthcare Disparities in African American Communities African Americans continue to face significant disparities in healthcare. From higher mortality rates for chronic conditions like cancer and heart disease to underdiagnosis of autoimmune disorders, these inequities stem from systemic racism, implicit bias, and a lack of cultural sensitivity among providers. Studies show that Black patients are less likely to receive adequate pain management and more likely to feel unheard or dismissed during medical visits. These disparities erode trust in the healthcare system and lead to poorer outcomes and avoidable suffering. For many, navigating the system can feel isolating and disempowering, leaving them ...

At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

A recent paper in the Frontiers in Medicine states that An underutilized intervention for long COVID is low dose naltrexone, which has an established safety profile for a variety of conditions. ‘Naltrexone is a non-selective opioid antagonist currently approved by the US Food and Drug Administration (FDA) for the treatment of alcohol and opioid dependence and is prescribed at 50–150 mg daily. At doses below 5 mg, it is considered low-dose naltrexone (LDN), exhibits anti-inflammatory and analgesic properties, and has been used off-label to reduce severity of symptoms in conditions such as fibromyalgia, multiple sclerosis, complex regional pain syndrome, myalgic encephalomyelitis/chronic fatigue ...

Unusual Suspects

Psychedelic Therapies Gain New Advocates Texas Law Magazine Written by Robin Berghaus. Art by Matthieu Bourel Published November 6, 2024 Marcus Capone served seven combat tours as a Navy SEAL — including missions with SEAL Team Six, the nation’s preeminent counterterrorism unit — before being medically retired in 2013. For years, he struggled to find effective treatments for his traumatic brain injuries, depression, and post-traumatic stress disorder. Capone tried antidepressants, talk therapy, hyperbaric oxygen therapy, transcranial magnetic stimulation, and he visited several brain clinics. Nothing worked. When Capone’s life began falling apart, he considered suicide. His wife was just as ...